Clinical analysis of pulmonary fungal infection in patients aged 80 and over
Yuan Xuey
Abstract
Yuan Xuey
Abstract
Objective To find out the clinical features, the type of fungal infection, the risk factors and prognosis of pulmonary fungal infection in patients aged 80 and over. Methods The clinical data of fifty-six patients aged 80 and over with pulmonary fungal infection were retrospectively analyzed. Results All patients presented with basis diseases. Chronic obstructive pulmonary disease (COPD), diabetes and tumor were main basis diseases. Blastocystis were main pathogenic bacteria type. Conclusions All the clinical manifestations of pulmonary fungal infection in patients aged 80 and over were not specific. Pulmonary fungal infection is an important cause of the secondary infection in many diseases. Long term use of antibiotics and diabetes may be the risk factors.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To find out the clinical features, the type of fungal infection, the risk factors and prognosis of pulmonary fungal infection in patients aged 80 and over. Methods The clinical data of fifty-six patients aged 80 and over with pulmonary fungal infection were retrospectively analyzed. Results All patients presented with basis diseases. Chronic obstructive pulmonary disease (COPD), diabetes and tumor were main basis diseases. Blastocystis were main pathogenic bacteria type. Conclusions All the clinical manifestations of pulmonary fungal infection in patients aged 80 and over were not specific. Pulmonary fungal infection is an important cause of the secondary infection in many diseases. Long term use of antibiotics and diabetes may be the risk factors.
Key concepts: Medicine, Pulmonary infection, COPD, Pulmonary disease, Diabetes mellitus, Antibiotics, Internal medicine, Disease